Inflammation-mediated abrogation of androgen signaling: An in vitro model of prostate cell inflammation

Molecular Carcinogenesis

Volumn 53, Issue 2, 2014, Pages 85-97

  Debelec Butuner, Bilge ^a   Alapinar, Cansu ^a   Varisli, Lokman ^a,b   Erbaykent Tepedelen, Burcu ^a   Hamid, Syed Muhammad ^a,c   Gonen Korkmaz, Ceren ^a   Korkmaz, Kemal Sami ^a  

^a EGE UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Androgen; DNA damage; Inflammation; Loss of p53; NFkB; Prostate; ROS

Indexed keywords

ACETIC ACID; ANDROGEN; GELATINASE B; GLUTATHIONE PEROXIDASE 2; HISTONE H2AX; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KLK 4 PROTEIN; LIPOPOLYSACCHARIDE; NEUTROPHIL COLLAGENASE; NKX 3.1 PROTEIN; PHORBOL ACETATE; PROTEIN; PROTEIN P21; PROTEIN P53; PSA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA DAMAGE; DOWN REGULATION; GENETIC HETEROGENEITY; HISTONE PHOSPHORYLATION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROSTATE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

ANDROGEN; DNA DAMAGE; INFLAMMATION; LOSS OF P53; NFKB; PROSTATE; ROS;

ACETYLCYSTEINE; ANDROGENS; ANTIOXIDANTS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; GLUTATHIONE PEROXIDASE; HOMEODOMAIN PROTEINS; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; KALLIKREINS; LYSINE; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PHOSPHORYLATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; PROTO-ONCOGENE PROTEINS C-MDM2; REACTIVE OXYGEN SPECIES; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; U937 CELLS; UP-REGULATION;

EID: 84892884295     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21948     Document Type: Article

References (34)

1. Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer 2007; 121:2373-2380.
2. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2009; 11:1289-1299.
3. Morgan MJ, Kim YS, Liu ZG. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 2008; 18:343-349.
4. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med 2010; 49:1603-1616.
5. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: Interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010; 31:37-49.
6. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett 2009; 282:125-136.
7. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 2011; 21:103-115.
8. Minelli A, Bellezza I, Conte C, Culig Z. Oxidative stress-related aging: A role for prostate cancer? Biochim Biophys Acta 2009; 1795:83-91.
9. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7:256-269.
10. Tam NN, Gao Y, Leung YK, Ho SM. Androgenic regulation of oxidative stress in the rat prostate: Involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 2003; 163:2513-2522.
11. Rokhlin OW, Taghiyev AF, Bayer KU, et al. Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival. Cancer Biol Ther 2007; 6:732-742.
12. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther 2008; 7:1288-1296.
13. Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 2005; 65:6773-6779.
14. Markowski MC, Bowen C, Gelmann EP. Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res 2008; 68:6896-6901.
15. Bieberich CJ, Fujita K, He WW, Jay G. Prostate-specific and androgen-dependent expression of a novel homeobox gene. J Biol Chem 1996; 271:31779-31782.
16. Korkmaz KS, Korkmaz CG, Ragnhildstveit E, Kizildag S, Pretlow TG, Saatcioglu F. Full-length cDNA sequence and genomic organization of human NKX3A-Alternative forms and regulation by both androgens and estrogens. Gene 2000; 260:25-36.
17. Korkmaz CG, Korkmaz KS, Manola J, et al. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J Urol 2004; 172:1134-1139.
18. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2009; 31:37-49.
19. Jablonska E, Piotrowski L, Grabowska Z. Serum levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997; 3:126-129.
20. Lacroix L, Nocera M, Mian C, et al. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 2001; 11:1017-1023.
21. Naiki-Ito A, Asamoto M, Hokaiwado N, et al. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens. Cancer Res 2007; 67:11353-11358.
22. Florian S, Wingler K, Schmehl K, et al. Cellular and subcellular localization of gastrointestinal glutathione peroxidase in normal and malignant human intestinal tissue. Free Radic Res 2001; 35:655-663.
23. Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 2001; 142:4795-4805.
24. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1:34-45.
25. Allen GD. MODFIT: A pharmacokinetics computer program. Biopharm Drug Dispos 1990; 11:477-498.
26. Yu YP, Yu G, Tseng G, et al. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67:8043-8050.
27. Utomo A, Jiang X, Furuta S, et al. Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. J Biol Chem 2004; 279:43522-43529.
28. van der Velden LA, Schaafsma HE, Manni JJ, Ruiter DJ, Ramaekers FC, Kuijpers W. Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol 1997; 254:376-383.
29. Redondo S, Ruiz E, Gordillo-Moscoso A, et al. Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: A link between inflammation and apoptosis. Diabetologia 2011; 54:190-199.
30. Gresner P, Gromadzinska J, Jablonska E, Kaczmarski J, Wasowicz W. Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer 2009; 65:34-40.
31. Meyer HA, Hollenbach B, Stephan C, et al. Reduced serum selenoprotein P concentrations in German prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2009; 18:2386-2390.
32. Culig Z, Hobisch A, Herold M, et al. Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells. Br J Cancer 1998; 78:1004-1011.
33. Khalili M, Mutton LN, Gurel B, Hicks JL, De Marzo AM, Bieberich CJ. Loss of Nkx3.1 expression in bacterial prostatitis: A potential link between inflammation and neoplasia. Am J Pathol 2010; 176:2259-2268.
34. Martin K, Viera K, Petr C, Marie N, Eva T. Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique and of probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors. Mediators Inflamm 2006; 2006:65237.